Proactive Investors - Run By Investors For Investors

Crescita Therapeutics Signs Pliaglis Out-Licensing Agreement with Cantabria Labs

Crescita Therapeutics (TSE:CTX-OTC:CFFTF) President and CEO Serge Verreault joined Steve Darling from Proactive Investors Vancouver to discuss the dermatology company signing a big deal with Cantabria Labs for their product Pliaglis. 

Verreault telling Proactive how much that is worth to the company and which markets the deal opens up.

View full CTX profile View Profile

Crescita Therapeutics Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use